Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

C, Fermé; H, Eghbali; JH, Meerwaldt; C, Rieux; J, Bosq; F, Berger; T, Girinsky; P, Brice; Veer MB, van't; JA, Walewski; P, Lederlin; U, Tirelli; P, Carde; den Neste E, Van; E, Gyan; M, Monconduit; M, Diviné; JM, Raemaekers; G, Salles; EM, Noordijk; GJ, Creemers; J, Gabarre; A, Hagenbeek; O, Reman; M, Blanc; J, Thomas; B, Vié; JC, Kluin-Nelemans; F, Viseu; JW, Baars; P, Poortmans; PJ, Lugtenburg; C, Carrie; J, Jaubert; M, Henry-Amar

doi:10.1056/nejmoa064601

Public

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

Shared by NobleBlocks on Nov 1, 2007 • 12:00 AM UTC

Authors:

Fermé C

Eghbali H

Meerwaldt JH

Abstract

Background Treatment of early-stage Hodgkin's disease is usually tailored in line with prognostic factors that allow for reductions in the amount of chemotherapy and extent of radiotherapy required for a possible cure.Methods From 1993 to 1999, we identified 1538 patients (age, 15 to 70 years) who h...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!